tirzepatide surmount-1 weight loss percent 72 weeks for the Maintenance of Body Reduction: Rationale, Design, and Baseline Characteristics of SURMOUNT‐MAINTAIN - Horn - 2025 - Obesity Adults with obesity using tirzepatide

Effect of glucagon-like peptide-1 receptor agonists on renal function: A meta-analysis of randomized controlled trials

Erythrocytes functionality in SARS-CoV-2 infection: potential link with alzheimers disease

Microcirculation Animal studies suggest that GLP-1R agonists enhance microvascular function and myocardial perfusion

Clinically significant vitamin B 12 deficiency and megaloblastic anemia are unlikely, unless these drug therapies are prolonged for two or more years, or if in addition, the person's dietary intake is below recommended levels

"Conformational changes on substrate binding to methylmalonyl CoA mutase and new insights into the free radical mechanism"